Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Long-Term Investments (2018 - 2019)

Avai Bio's Long-Term Investments history spans 2 years, with the latest figure at $1100.0 for Q4 2019.

  • On a quarterly basis, Long-Term Investments changed N/A to $1100.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $1100.0, a N/A change, with the full-year FY2019 number at $1325.0, down 84.06% from a year prior.
  • Long-Term Investments hit $1100.0 in Q4 2019 for Avai Bio, down from $15847.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for AVAI hit a ceiling of $63995.0 in Q3 2018 and a floor of $1100.0 in Q4 2019.